Delivery Order SPE2DB24D1201-SPE2DB25FJBBQ
Award Date
1/2/25
Potential Completion Date
1/3/25
Potential Value
$2.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of JATENZO 237 MG CAPSULE 120S. The $2,188.14 firm fixed-price delivery order contract has an ultimate completion date of November 15, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a comprehensive range of...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,395.61 Firm Fixed Price Delivery Order contract covers the supply of JATENZO 237 MG CAPSULE 120S, a specialty pharmaceutical product. The contract has an ultimate completion date of December 13, 2024.
AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The U.S. Defense Logistics Agency (DLA) awarded a $2,902.10 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to supply the drug JATENZO 237 MG CAPSULE 120S. This contract has a period of performance through July 29, 2024 and does not utilize a set-aside designation. Amerisourcebergen has been awarded multiple indefinite delivery contracts (IDCs) by DLA Troop Support Medical and the Department of Justice Federal Bureau of...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,131.88 firm fixed-price delivery order is for the supply of the drug product JATENZO 158 MG CAPSULE 120S, with a completion date of December 9, 2024. The contract does not have a set-aside designation, indicating open competition.
Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,131.87 firm fixed-price delivery order contract is for the supply of JATENZO 237 MG capsules. This award does not have any set-aside designations, indicating open competition.
AmerisourceBergen holds a substantial $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $3,282.21, is for the delivery of JATENZO 237 MG CAPSULE 120S, a medical product. This contract has no set-aside designation, indicating open competition.
AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award from the Defense Logistics Agency (DLA) was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of JATENZO 237 MG Capsule 120S. The $1,094.07 firm fixed price contract has a completion date of November 5, 2024. It was issued as a delivery order and does not have a set-aside designation, indicating open competition.
Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) for the delivery of JATENZO 237 MG CAPSULE 120S, a pharmaceutical product. The $1,263.07 firm fixed price delivery order was issued under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the primary contract vehicle for Amerisourcebergen to...
This federal contract award is for the delivery of JATENZO 237 MG CAPSULE 120S, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,951.93, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 30, 2024. The contract has a period of performance through July 31, 2024 and is a Firm Fixed Price Delivery Order. No set-aside was used for this award. Amerisourcebergen Drug Corp holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of the pharmaceutical product JATENZO 237 MG Capsule 120S. The contract has a firm fixed price of $2,188.14 and a completion date of September 20, 2024. AmerisourceBergen, as a major pharmaceutical distributor, will provide this medication to support military treatment facilities and other government healthcare programs. The contract does not have a set-aside...